AI in healthcare, Therapeutics
2 known investors
Quantum Lens develops a quantum computing and AI platform for drug discovery that simulates molecular behavior at the atomic level to guide the design of novel drug candidates. The platform targets pharmaceutical companies and biotech researchers working on small-molecule drug discovery, particularly for challenging targets like covalent inhibitors, hard-to-drug enzymes, and allosteric binding sites.